RPG Life Sciences Limited (IN:RPGLIFE)
:RPGLIFE
Want to see IN:RPGLIFE full AI Analyst Report?
Total Valuation
RPG Life Sciences Limited has a market cap or net worth of ₹36.58B. The enterprise value is ₹36.22B.
Market Cap₹36.58B
Enterprise Value₹36.22B
Share Statistics
RPG Life Sciences Limited has 16,539,015 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,539,015
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
RPG Life Sciences Limited’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 14.68%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)14.68%
Return on Capital Employed (ROCE)0.20
Revenue Per Employee5.57M
Profits Per Employee906.85K
Employee Count1,270
Asset Turnover0.89
Inventory Turnover3.35
Valuation Ratios
The current PE Ratio of RPG Life Sciences Limited is 26.7. RPG Life Sciences Limited’s PEG ratio is -0.72.
PE Ratio26.7
PS Ratio4.34
PB Ratio5.08
Price to Fair Value5.08
Price to FCF-38.40K
Price to Operating Cash Flow327.62
PEG Ratio-0.72
Income Statement
In the last 12 months, RPG Life Sciences Limited had revenue of 7.08B and earned 1.15B in profits. Earnings per share was 69.64.
Revenue7.08B
Gross Profit2.92B
Operating Income1.26B
Pretax Income1.54B
Net Income1.15B
EBITDA1.47B
Earnings Per Share (EPS)69.64
Cash Flow
In the last 12 months, operating cash flow was 112.70M and capital expenditures -319.70M, giving a free cash flow of -207.00M billion.
Operating Cash Flow112.70M
Free Cash Flow-207.00M
Free Cash Flow per Share-12.52
Dividends & Yields
RPG Life Sciences Limited pays an annual dividend of ₹20, resulting in a dividend yield of 0.85%
Dividend Per Share₹20
Dividend Yield0.85%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.79
52-Week Price Change4.82%
50-Day Moving Average2.07K
200-Day Moving Average2.20K
Relative Strength Index (RSI)49.29
Average Volume (3m)3.23K
Important Dates
RPG Life Sciences Limited upcoming earnings date is Jul 24, 2026, TBA (Confirmed).
Last Earnings DateApr 29, 2026
Next Earnings DateJul 24, 2026
Ex-Dividend Date―
Financial Position
RPG Life Sciences Limited as a current ratio of 3.48, with Debt / Equity ratio of 3.30%
Current Ratio3.48
Quick Ratio2.71
Debt to Market Cap<0.01
Net Debt to EBITDA-1.17
Interest Coverage Ratio141.13
Taxes
In the past 12 months, RPG Life Sciences Limited has paid 390.30M in taxes.
Income Tax390.30M
Effective Tax Rate0.25
Enterprise Valuation
RPG Life Sciences Limited EV to EBITDA ratio is 19.72, with an EV/FCF ratio of -36.26K.
EV to Sales4.10
EV to EBITDA19.72
EV to Free Cash Flow-36.26K
EV to Operating Cash Flow44.43
Balance Sheet
RPG Life Sciences Limited has ₹2.24B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹2.24B billion.
Cash & Marketable Securities₹2.24B
Total Debt₹0.00
Net Cash₹2.24B
Net Cash Per Share₹135.15
Tangible Book Value Per Share₹366.04
Margins
Gross margin is 46.83%, with operating margin of 17.75%, and net profit margin of 16.28%.
Gross Margin46.83%
Operating Margin17.75%
Pretax Margin21.79%
Net Profit Margin16.28%
EBITDA Margin20.79%
EBIT Margin17.75%
Analyst Forecast
The average price target for RPG Life Sciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast8.28%
EPS Growth Forecast-37.15%